# Adenosine A2A receptors regulate D2-type medium spiny neurons in the nucleus accumbens to mediate pain and depression comorbidity

**Authors:** Dongyu Zhou, Xiaona Yang, Lingzhen Song, Mengyu Wu, Hongxing Zhang, Jun-Li Cao, Su Min

PMC · DOI: 10.3389/fphar.2026.1759544 · Frontiers in Pharmacology · 2026-02-23

## TL;DR

This study shows how specific brain cells in the nucleus accumbens regulate both pain and depression-like symptoms through adenosine A2A receptors.

## Contribution

The study identifies a novel role for adenosine A2A receptors in regulating pain and depression comorbidity via D2-type medium spiny neurons in the nucleus accumbens.

## Key findings

- Chemogenetic activation of NAcS D2-MSNs induces pain and behavioral despair in mice.
- A2ARs modulate the excitability of D2-MSNs and influence pain and depression-like behaviors.
- Local A2AR agonists and antagonists bidirectionally affect pain and despair in both healthy and injured mice.

## Abstract

Persistent pathological pain often induces comorbid depressive-like symptoms, yet the underlying neuronal and molecular mechanisms remain unclear. The nucleus accumbens shell (NAcS) has been implicated in mediating pain sensation and emotional disorders, including depression. However, how it regulates pain-depression comorbidity (PDC) is not well-known. In the present study, we demonstrated that D2-type medium spiny neurons (D2-MSNs) in the NAcS bidirectionally modulated pain and its comorbid behavioral despair measured in the forced swimming test (FST), an effect possibly involving adenosine A2A receptors (A2ARs). Specifically, acute chemogenetic activation of NAcS D2-MSNs induced thermal/mechanical pain in naïve mice but did not affect despair-like behavior in the FST, a phenomenon that occurred after repeated activation of these neurons. Conversely, chemogenetic inhibition of NAcS D2-MSNs alleviated spared nerve injury (SNI) induced neuropathic pain and its comorbid behavioral despair. Our immunofluorescent staining revealed a relatively enriched expression of A2ARs in NAcS D2-MSNs. Ex vivo electrophysiological recordings revealed that activating and inhibiting A2ARs increased and decreased the neuronal excitability of NAcS D2-MSNs. Consistently, local infusion of the agonist and antagonist of A2ARs into the NAcS bidirectionally modulated pain and despair-like behaviors in both naïve and SNI mice. Together, these findings demonstrate the functional role of NAcS D2-MSNs in mediating PDC, which was possibly modulated by local A2ARs, thus providing a potential therapeutic target for PDC.

## Linked entities

- **Diseases:** depression (MONDO:0002050)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Rbfox3 (RNA binding protein, fox-1 homolog (C. elegans) 3) [NCBI Gene 52897] {aka Fox-3, Hrnbp3, NeuN, Neuna60}, Slc17a7 (solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7) [NCBI Gene 72961] {aka 2900052E22Rik, Vglut1}, Syp (synaptophysin) [NCBI Gene 20977] {aka A230093K24Rik, Syn, p38}, Aif1 (allograft inflammatory factor 1) [NCBI Gene 11629] {aka AIF-1, D17H6S50E, G1, Iba1}, Grin2b (glutamate receptor, ionotropic, NMDA2B (epsilon 2)) [NCBI Gene 14812] {aka GluN2B, GluRepsilon2, NR2B, Nmdar2b}, Drd1 (dopamine receptor D1) [NCBI Gene 13488] {aka C030036C15Rik, Drd-1, Drd1a, Gpcr15}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 12772] {aka Cc-ckr-2, Ccr2a, Ccr2b, Ckr2, Ckr2a, Ckr2b}, Drd2 (dopamine receptor D2) [NCBI Gene 13489] {aka D2R, Drd-2}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Car2 (carbonic anhydrase 2) [NCBI Gene 12349] {aka CAII, Ca2, Car-2, Ltw-5, Lvtw-5}, Grin1 (glutamate receptor, ionotropic, NMDA1 (zeta 1)) [NCBI Gene 14810] {aka GluN1, GluRdelta1, GluRzeta1, M100174, NMD-R1, NMDAR1}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], Adora2a (adenosine A2a receptor) [NCBI Gene 11540] {aka A2AAR, A2aR, AA2AR, ARA2A}, ADORA2A (adenosine A2a receptor) [NCBI Gene 135] {aka A2aR, ADORA2, RDC8}
- **Diseases:** hypersensitivity (MESH:D004342), depression (MESH:D003866), Chronic pain (MESH:D059350), neuropathic pain (MESH:D009437), trigeminal neuralgia (MESH:D014277), REM-SD (MESH:D020187), cognitive dysfunction (MESH:D003072), hyperalgesia (MESH:D006930), SNI (MESH:D000080902), infection (MESH:D007239), affective (MESH:D019964), emotional disorders (MESH:D009358), spinal cord injury (MESH:D013119), convulsions (MESH:D012640), motivational deficits (MESH:D009461), PDC (MESH:D010146), anhedonia (MESH:D059445), inflammatory (MESH:D007249), anxiety (MESH:D001007), trigeminal nerve injury (MESH:D061221), psychiatric disorders (MESH:D001523)
- **Chemicals:** sucrose (MESH:D013395), PFA (MESH:C003043), EGTA (MESH:D004533), CO2 (MESH:D002245), ATP (MESH:D000255), DMSO (MESH:D004121), povidone-iodine (MESH:D011206), D-glucose (MESH:D005947), Tween-20 (MESH:D011136), PBS (MESH:D007854), dopamine (MESH:D004298), KCl (MESH:D011189), HEPES (MESH:D006531), Alexa 594 (MESH:C417664), Clozapine-N-oxide (MESH:C079149), Na (MESH:D012964), SCH 58261 (MESH:C098657), NaHCO3 (MESH:D017693), A2ARs (-), MgSO4 (MESH:D008278), CGS 21680 (MESH:C061282), isoflurane (MESH:D007530), water (MESH:D014867), CaCl2 (MESH:D002122), Na2 (MESH:C033479), NaCl (MESH:D012965), adenosine (MESH:D000241), clozapine (MESH:D003024), GTP (MESH:D006160), MgCl2 (MESH:D015636), pentobarbital sodium (MESH:D010424)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], adeno-associated virus 2 (no rank) [taxon 10804], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C +- 1  C, A 2A, C-4  C, A2A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968297/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968297/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968297/full.md

---
Source: https://tomesphere.com/paper/PMC12968297